Clinical trials

Sense of Smell May Predict Risk for Cognitive Decline

Two studies presented at the 2014 Alzheimer’s Association International Conference (AICC) in Copenhagen this month demonstrated that a decrease in the ability to identify odors was significantly associated with loss of brain cell function and progression to Alzheimer’s disease. There is growing evidence that the decreased ability to correctly identify odors is a predictor of cognitive impairment and an […]

Read More
DETAIL

Reasons Alzheimer’s Patients are Omitted from Clinical Trials

A study in the British Journal of Clinical Pharmacology assessed the reasons that prevent Alzheimer’s disease (AD) patients from being included in clinical trials. It is interesting that no study has evaluated the main medical and non-medical factors that explain the non-inclusion in studies. While reviewing the database of a dementia clinic for involving patients […]

Read More
DETAIL